<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36685555</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Inflammatory markers and pulmonary function in adolescents and young adults 6 months after mild COVID-19.</ArticleTitle><Pagination><StartPage>1081718</StartPage><MedlinePgn>1081718</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1081718</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2022.1081718</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Both public and scientific attention have shifted from the acute COVID-19 illness to the chronic disability experienced by a proportion of COVID-19 convalescents. Post COVID-19 condition, a term used for long-lasting symptoms after COVID-19, can affect individuals across all disease severity and age groups. Data on post-COVID-19 symptomatology, epidemiology and pathophysiology in adolescents and young adults are scarce. To date, little is known on the immunological and pulmonary trends in these patients after COVID-19. This study investigated immunological markers and pulmonary function in non-hospitalized patients in this group at 6 months after initial mild COVID-19 infection.</AbstractText><AbstractText Label="METHODS">Non-hospitalized SARS-CoV-2 positive (n = 405) and SARS-CoV-2 negative (n = 111) adolescents and young adults (aged 12-25 years) were followed prospectively for six months after SARS-CoV-2 PCR testing. At baseline and at six months follow-up, all participants underwent an assessment including clinical examination, questionnaires, spirometry, and blood sampling. Cross-sectional comparisons of blood biomarkers; including white blood cell counts, CRP, GDF-15, a 27-multiplex cytokine assay, complement activation products and SARS-CoV-2 antibodies; and spirometry measures were performed after classification of all participants according to their COVID-19 status and adherence to post-COVID-19 case criteria. Associations between biomarkers and COVID-19 symptoms were explored.</AbstractText><AbstractText Label="RESULTS">No difference in pulmonary function was detected between the groups. COVID-19 convalescents had higher levels of chemokines eotaxin, MCP-1 and IP-10 than non-infected controls. The increase was modest and not associated with long-lasting COVID-19 symptoms.</AbstractText><AbstractText Label="DISCUSSION">Elevated inflammatory mediators were found in adolescents and young adults six months after mild COVID-19, but there was no association with post-COVID-19 condition.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Sommen, Havdal, Selvakumar, Einvik, Leegaard, Lund-Johansen, Michelsen, Mollnes, Stiansen-Sonerud, Tjade, Wyller and Berven.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sommen</LastName><ForeName>Silke Lauren</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Akershus University Hospital, L&#xf8;renskog, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Havdal</LastName><ForeName>Lise Beier</ForeName><Initials>LB</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Akershus University Hospital, L&#xf8;renskog, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Selvakumar</LastName><ForeName>Joel</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Akershus University Hospital, L&#xf8;renskog, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Einvik</LastName><ForeName>Gunnar</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Akershus University Hospital, L&#xf8;renskog, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leegaard</LastName><ForeName>Truls Michael</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Infection Control, Akershus University Hospital, L&#xf8;renskog, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lund-Johansen</LastName><ForeName>Fridtjof</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Immunology, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michelsen</LastName><ForeName>Annika E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mollnes</LastName><ForeName>Tom E</ForeName><Initials>TE</Initials><AffiliationInfo><Affiliation>Department of Immunology, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Laboratory, Nordland Hospital, Bod&#xf8;, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre of Molecular Inflammation Research, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, S&#xf8;r-Tr&#xf8;ndelag, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stiansen-Sonerud</LastName><ForeName>Tonje</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Akershus University Hospital, L&#xf8;renskog, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Molecular Biology (EpiGen), University of Oslo and Akershus University Hospital, L&#xf8;renskog, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tjade</LastName><ForeName>Trygve</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>F&#xfc;rst Medical Laboratory, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wyller</LastName><ForeName>Vegard Bruun Bratholm</ForeName><Initials>VBB</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Akershus University Hospital, L&#xf8;renskog, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berven</LastName><ForeName>Lise Lund</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Akershus University Hospital, L&#xf8;renskog, Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062072" MajorTopicYN="N">Patient Acuity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long Covid</Keyword><Keyword MajorTopicYN="N">Post-COVID-19</Keyword><Keyword MajorTopicYN="N">adolescent</Keyword><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">cytokine</Keyword><Keyword MajorTopicYN="N">immunology</Keyword><Keyword MajorTopicYN="N">pulmonary function</Keyword></KeywordList><CoiStatement>Author TT was employed by company F&#xfc;rst Medical Laboratory. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>23</Day><Hour>4</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36685555</ArticleId><ArticleId IdType="pmc">PMC9853911</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.1081718</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet (2021) 397(10270):220&#x2013;32. doi: 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KG, Brokstad KA, Zhou F, Linchausen DW, Hansen BA, et al. . Long COVID in a prospective cohort of home-isolated patients. Nat Med (2021) 27(9):1607&#x2013;13. doi: 10.1038/s41591-021-01433-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature (2021) 594(7862):259&#x2013;64. doi: 10.1038/s41586-021-03553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni E, Sudre CH, Canas LS, Bhopal SS, Hughes RC, Antonelli M, et al. . Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc Health (2021) 5(10):708&#x2013;18. doi: 10.1016/S2352-4642(21)00198-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00198-X</ArticleId><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>Caspersen IH, Magnus P, Trogstad L. Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort. Eur J Epidemiol (2022) 37(5):539&#x2013;48. doi: 10.1007/s10654-022-00847-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-022-00847-8</ArticleId><ArticleId IdType="pmc">PMC8872922</ArticleId><ArticleId IdType="pubmed">35211871</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post COVID-19 condition or long COVID: A meta-analysis and systematic review. J Infect Dis (2022) 6:jiac136. doi:&#xa0;10.1093/infdis/jiac136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis (2022) 22(4):e102&#x2013;e7. doi: 10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, Pinto Pereira SM, Shafran R, de Stavola BL, Rojas N, McOwat K, et al. . Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): A national matched cohort study. Lancet Child Adolesc Health (2022) 6(4):230&#x2013;9. doi: 10.1016/S2352-4642(22)00022-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00022-0</ArticleId><ArticleId IdType="pmc">PMC8820961</ArticleId><ArticleId IdType="pubmed">35143770</ArticleId></ArticleIdList></Reference><Reference><Citation>
UK Office for National Statistics (ONS) . All data related to prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK . Available at: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/ (Accessed 1 September 2022).</Citation></Reference><Reference><Citation>Behnood SA, Shafran R, Bennett SD, Zhang AXD, O'Mahoney LL, Stephenson TJ, et al. . Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studies. J Infect (2022) 84(2):158&#x2013;70. doi: 10.1016/j.jinf.2021.11.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.11.011</ArticleId><ArticleId IdType="pmc">PMC8604800</ArticleId><ArticleId IdType="pubmed">34813820</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong TL, Weitzer DJ. Long COVID and myalgic Encephalomyelitis/Chronic fatigue syndrome (ME/CFS)-a systemic review and comparison of clinical presentation and symptomatology. Med (Kaunas) (2021) 57(5):418. doi: 10.3390/medicina57050418</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristiansen MS, Stabursvik J, O'Leary EC, Pedersen M, Asprusten TT, Leegaard T, et al. . Clinical symptoms and markers of disease mechanisms in adolescent chronic fatigue following Epstein-Barr virus infection: An exploratory cross-sectional study. Brain Behav Immun (2019) 80:551&#x2013;63. doi: 10.1016/j.bbi.2019.04.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2019.04.040</ArticleId><ArticleId IdType="pubmed">31039432</ArticleId></ArticleIdList></Reference><Reference><Citation>Fevang B, Wyller VBB, Mollnes TE, Pedersen M, Asprusten TT, Michelsen A, et al. . Lasting immunological imprint of primary Epstein-Barr virus infection with associations to chronic low-grade inflammation and fatigue. Front Immunol (2021) 12:715102. doi: 10.3389/fimmu.2021.715102</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.715102</ArticleId><ArticleId IdType="pmc">PMC8721200</ArticleId><ArticleId IdType="pubmed">34987499</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. . Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol (2022) 23(2):210&#x2013;6. doi: 10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Lu S, Tang AF, Durstenfeld MS, Ho HE, Goldberg SA, et al. . Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. J Infect Dis (2021) 224(11):1839&#x2013;48. doi: 10.1093/infdis/jiab490</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. . Fatigue and cognitive impairment in post-COVID-19 syndrome: A systematic review and meta-analysis. Brain Behav Immun (2022) 101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Sante GD, Buonsenso D, De Rose C, Valentini P, Ria F, Sanguinetti M, et al. . Immune profile of children with post-acute sequelae of SARS-CoV-2 infection (Long covid). medRxiv (2021). doi: 10.1101/2021.05.07.21256539</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.07.21256539</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund Berven L, Selvakumar J, Havdal L, Stiansen-Sonerud T, Einvik G, Leegaard TM, et al. . Inflammatory markers, pulmonary function, and clinical symptoms in acute COVID-19 among non-hospitalized adolescents and young adults. Front Immunol (2022) 13:837288. doi: 10.3389/fimmu.2022.837288</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.837288</ArticleId><ArticleId IdType="pmc">PMC8864121</ArticleId><ArticleId IdType="pubmed">35222429</ArticleId></ArticleIdList></Reference><Reference><Citation>Havdal LB, Berven LL, Selvakumar J, Stiansen-Sonerud T, Leegaard TM, Tjade T, et al. . Neurological involvement in COVID-19 among non-hospitalized adolescents and young adults. Front Neurol (2022) 13:915712. doi: 10.3389/fneur.2022.915712</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.915712</ArticleId><ArticleId IdType="pmc">PMC9257204</ArticleId><ArticleId IdType="pubmed">35812102</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvakumar J, Havdal L, Drevvatne M, Brodwall E, Berven L, Stiansen-Sonerud T, et al. . Prevalence and predictors of long COVID among non-hospitalised adolescents and young adults: A prospective controlled cohort study. Research Square; (2022). doi:&#xa0;10.21203/rs.3.rs-2021203/v1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-2021203/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergseth G, Ludviksen JK, Kirschfink M, Giclas PC, Nilsson B, Mollnes TE. An international serum standard for application in assays to detect human complement activation products. Mol Immunol (2013) 56(3):232&#x2013;9. doi: 10.1016/j.molimm.2013.05.221</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2013.05.221</ArticleId><ArticleId IdType="pubmed">23787367</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran TT, Vaage EB, Mehta A, Chopra A, Kolderup A, Anthi A, et al. . Titers of antibodies the receptor-binding domain (RBD) of ancestral SARS-CoV-2 are predictive for levels of neutralizing antibodies to multiple variants. bioRxiv (2022). doi: 10.1101/2022.03.26.484261</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.03.26.484261</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, et al. . Development of a fatigue scale. J Psychosom. Res (1993) 37:147&#x2013;53. doi: 10.1016/0022-3999(93)90081-P</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3999(93)90081-P</ArticleId><ArticleId IdType="pubmed">8463991</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedree H, Sunnquist M, Jason LA. The DePaul symptom questionnaire-2: A validation study. Fatigue (2019) 7(3):166&#x2013;79. doi: 10.1080/21641846.2019.1653471</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2019.1653471</ArticleId><ArticleId IdType="pmc">PMC7367506</ArticleId><ArticleId IdType="pubmed">32685281</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott J, Whitaker M, Bodinier B, Eales O, Riley S, Ward H, et al. . Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people. PloS Med (2021) 18(9):e1003777. doi: 10.1371/journal.pmed.1003777</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003777</ArticleId><ArticleId IdType="pmc">PMC8478234</ArticleId><ArticleId IdType="pubmed">34582457</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen M, Asprusten TT, Godang K, Leegaard TM, Osnes LT, Skovlund E, et al. . Predictors of chronic fatigue in adolescents six months after acute Epstein-Barr virus infection: A prospective cohort study. Brain Behav Immun (2019) 75:94&#x2013;100. doi: 10.1016/j.bbi.2018.09.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2018.09.023</ArticleId><ArticleId IdType="pubmed">30261303</ArticleId></ArticleIdList></Reference><Reference><Citation>Morriss RK, Wearden AJ, Mullis R. Exploring the validity of the chalder fatigue scale in chronic fatigue syndrome. J Psychosom. Res (1998) 45(5):411&#x2013;7. doi: 10.1016/S0022-3999(98)00022-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3999(98)00022-1</ArticleId><ArticleId IdType="pubmed">9835234</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K SS, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: A comprehensive approach to its definition and study. international chronic fatigue syndrome study group. Ann Intern Med (1994) 121(12):953&#x2013;9. doi: 10.7326/0003-4819-121-12-199412150-00009</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType="pubmed">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. . Standardization of spirometry 2019 update. an official American thoracic society and European respiratory society technical statement. Am J Respir Crit Care Med (2019) 200(8):e70&#x2013;88. doi: 10.1164/rccm.201908-1590ST</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201908-1590ST</ArticleId><ArticleId IdType="pmc">PMC6794117</ArticleId><ArticleId IdType="pubmed">31613151</ArticleId></ArticleIdList></Reference><Reference><Citation>Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al. . Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J (2012) 40(6):1324&#x2013;43. doi: 10.1183/09031936.00080312</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00080312</ArticleId><ArticleId IdType="pmc">PMC3786581</ArticleId><ArticleId IdType="pubmed">22743675</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, et al. . Evolution of antibody immunity to SARS-CoV-2. Nature (2021) 591(7851):639&#x2013;44. doi: 10.1038/s41586-021-03207-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation. Pathogens (2021) 10(6):763. doi: 10.3390/pathogens10060763</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10060763</ArticleId><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. . Multiple early factors anticipate post-acute COVID-19 sequelae. Cell (2022) 185(5):881&#x2013;95.e20. doi: 10.1016/j.cell.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Rankin SM, Conroy DM, Williams TJ. Eotaxin and eosinophil recruitment: Implications for human disease. Mol Med Today (2000) 6(1):20&#x2013;7. doi: 10.1016/S1357-4310(99)01635-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1357-4310(99)01635-4</ArticleId><ArticleId IdType="pubmed">10637571</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggiolini M, Dewals B, Moser B. Human chemokines: An update. Annu Rev Immunol (1997) 15(1):675&#x2013;705. doi: 10.1146/annurev.immunol.15.1.675</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.15.1.675</ArticleId><ArticleId IdType="pubmed">9143704</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J, Wood J, Jaycox J, Lu P, Dhodapkar RM, Gehlhausen JR, et al. . Distinguishing features of long COVID identified through immune profiling. medRxiv (2022) 2022:08. doi: 10.1101/2022.08.09.22278592</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.09.22278592</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung CCL, Goh D, Lim X, Tien TZ, Lim JCT, Lee JN, et al. . Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut (2022) 71(1):226&#x2013;9. doi: 10.1136/gutjnl-2021-324280</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324280</ArticleId><ArticleId IdType="pubmed">34083386</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergamaschi L, Mescia F, Turner L, Hanson AL, Kotagiri P, Dunmore BJ, et al. . Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease. Immunity (2021) 54(6):1257&#x2013;75.e8. doi: 10.1016/j.immuni.2021.05.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.05.010</ArticleId><ArticleId IdType="pmc">PMC8125900</ArticleId><ArticleId IdType="pubmed">34051148</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan FJ, Hope CM, Masavuli MG, Lynn MA, Mekonnen ZA, Yeow AEL, et al. . Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Med (2022) 20(1):26. doi: 10.1186/s12916-021-02228-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02228-6</ArticleId><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Krogstad H, Loge JH, Grotmol KS, Kaasa S, Kiserud CE, Salvesen O, et al. . Symptoms in the general Norwegian adult population - prevalence and associated factors. BMC Public Health (2020) 20(1):988. doi: 10.1186/s12889-020-09109-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-020-09109-2</ArticleId><ArticleId IdType="pmc">PMC7310321</ArticleId><ArticleId IdType="pubmed">32576168</ArticleId></ArticleIdList></Reference><Reference><Citation>White PD, Thomas JM, Amess J, Crawford DH, Grover SA, Kangro HO, et al. . Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br J Psychiatry (1998) 173:475&#x2013;81. doi: 10.1192/bjp.173.6.475</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.173.6.475</ArticleId><ArticleId IdType="pubmed">9926075</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I, Davenport T, Wakefield D, Vollmer-Conna U, Cameron B, Vernon SD, et al. . Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: Prospective cohort study. BMJ (2006) 333(7568):575. doi: 10.1136/bmj.38933.585764.AE</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38933.585764.AE</ArticleId><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Stenken JA, Poschenrieder AJ. Bioanalytical chemistry of cytokines&#x2013;a review. Anal Chim Acta (2015) 853:95&#x2013;115. doi: 10.1016/j.aca.2014.10.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aca.2014.10.009</ArticleId><ArticleId IdType="pmc">PMC4717841</ArticleId><ArticleId IdType="pubmed">25467452</ArticleId></ArticleIdList></Reference><Reference><Citation>Henno LT, Storjord E, Christiansen D, Bergseth G, Ludviksen JK, Fure H, et al. . Effect of the anticoagulant, storage time and temperature of blood samples on the concentrations of 27 multiplex assayed cytokines - consequences for defining reference values in healthy humans. Cytokine (2017) 97:86&#x2013;95. doi: 10.1016/j.cyto.2017.05.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2017.05.014</ArticleId><ArticleId IdType="pubmed">28595117</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>